jueves, 23 de enero de 2020

NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment | HIV.gov

NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment | HIV.gov

model of VRC01 antibody

NIAID Launches First Clinical Trial to Test Antibody-Drug Combination for Long-Acting HIV Treatment
The first clinical trial to test the combination of a long-acting anti-HIV drug plus a powerful HIV antibody as a long-acting treatment for people living with HIV has begun...
LEARN MORE

No hay comentarios:

Publicar un comentario